Multiple endocrine neoplasia type 1 epidemiology and demographics

Jump to navigation Jump to search

Multiple endocrine neoplasia type 1 Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple endocrine neoplasia type 1 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple endocrine neoplasia type 1 epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple endocrine neoplasia type 1 epidemiology and demographics

CDC on Multiple endocrine neoplasia type 1 epidemiology and demographics

Multiple endocrine neoplasia type 1 epidemiology and demographics in the news

Blogs on Multiple endocrine neoplasia type 1 epidemiology and demographics

Directions to Hospitals Treating Multiple endocrine neoplasia type 1

Risk calculators and risk factors for Multiple endocrine neoplasia type 1 epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Epidemiology and Demographics

Prevalence

  • Worldwide, the prevalence of Multiple endocrine neoplasia type 1 is estimated to be 2-3 per 100,000
  • Multiple endocrine neoplasia type 1 is a rare disease that occurs in approximately one in 30,000 individuals.

Age

  • Endocrine and non-endocrine manifestations of the disease in MEN1 patients most often begin in the fourth or fifth decade. The onset of the disease is rare before age 10 years.

Gender

  • Men and women are affected equally by multiple endocrine neoplasia type 1.
  • Males have a higher incidence of pancreatic tumors.
  • Females have a higher incidence of pituitary tumors.
  • Thymic tumors are found in men.

References


Template:WikiDoc Sources